412 related articles for article (PubMed ID: 37175869)
1. Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets.
Tanase DM; Valasciuc E; Gosav EM; Ouatu A; Buliga-Finis ON; Floria M; Maranduca MA; Serban IL
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175869
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
3. NLRP3 inflammasome pathways in atherosclerosis.
Baldrighi M; Mallat Z; Li X
Atherosclerosis; 2017 Dec; 267():127-138. PubMed ID: 29126031
[TBL] [Abstract][Full Text] [Related]
4. Sendai Virus V Protein Inhibits the Secretion of Interleukin-1β by Preventing NLRP3 Inflammasome Assembly.
Komatsu T; Tanaka Y; Kitagawa Y; Koide N; Naiki Y; Morita N; Gotoh B; Yokochi T
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021903
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 Inflammasome as a Common Denominator of Atherosclerosis and Abdominal Aortic Aneurysm.
Takahashi M
Circ J; 2021 Nov; 85(12):2129-2136. PubMed ID: 33883388
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis.
Hettwer J; Hinterdobler J; Miritsch B; Deutsch MA; Li X; Mauersberger C; Moggio A; Braster Q; Gram H; Robertson AAB; Cooper MA; Groß O; Krane M; Weber C; Koenig W; Soehnlein O; Adamstein NH; Ridker P; Schunkert H; Libby P; Kessler T; Sager HB
Cardiovasc Res; 2022 Oct; 118(13):2778-2791. PubMed ID: 34718444
[TBL] [Abstract][Full Text] [Related]
7. Potential Mechanisms and Effects of Chinese Medicines in Treatment of Diabetic Atherosclerosis by Modulating NLRP3 Inflammasome: A Narrative Review.
Yuan JY; Fu Y; Feng ZH; Sang F; Shao MY; Li LL
Chin J Integr Med; 2022 Aug; 28(8):753-761. PubMed ID: 35507299
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.
Grebe A; Hoss F; Latz E
Circ Res; 2018 Jun; 122(12):1722-1740. PubMed ID: 29880500
[TBL] [Abstract][Full Text] [Related]
9. [Advances in mechanisms for NLRP3 inflammasomes regulation].
Liu W; Guo WJ; Xu Q; Sun Y
Yao Xue Xue Bao; 2016 Oct; 51(10):1505-12. PubMed ID: 29924571
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction.
Silvis MJM; Demkes EJ; Fiolet ATL; Dekker M; Bosch L; van Hout GPJ; Timmers L; de Kleijn DPV
J Cardiovasc Transl Res; 2021 Feb; 14(1):23-34. PubMed ID: 32648087
[TBL] [Abstract][Full Text] [Related]
11. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 inflammasome in endothelial dysfunction.
Bai B; Yang Y; Wang Q; Li M; Tian C; Liu Y; Aung LHH; Li PF; Yu T; Chu XM
Cell Death Dis; 2020 Sep; 11(9):776. PubMed ID: 32948742
[TBL] [Abstract][Full Text] [Related]
13. Role of nucleotide binding oligomerization domain-like receptor protein 3 inflammasome in stress-induced gastric injury.
Higashimori A; Watanabe T; Nadatani Y; Nakata A; Otani K; Hosomi S; Tanaka F; Kamata N; Taira K; Nagami Y; Tanigawa T; Fujiwara Y
J Gastroenterol Hepatol; 2021 Mar; 36(3):740-750. PubMed ID: 32918847
[TBL] [Abstract][Full Text] [Related]
14. Atherothrombosis and the NLRP3 inflammasome - endogenous mechanisms of inhibition.
Satish M; Agrawal DK
Transl Res; 2020 Jan; 215():75-85. PubMed ID: 31469975
[TBL] [Abstract][Full Text] [Related]
15. Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis.
Qiao L; Ma J; Zhang Z; Sui W; Zhai C; Xu D; Wang Z; Lu H; Zhang M; Zhang C; Chen W; Zhang Y
Circ Res; 2021 Dec; 129(12):1141-1157. PubMed ID: 34704457
[TBL] [Abstract][Full Text] [Related]
16. Interactions between PCSK9 and NLRP3 inflammasome signaling in atherosclerosis.
Wang Y; Fang D; Yang Q; You J; Wang L; Wu J; Zeng M; Luo M
Front Immunol; 2023; 14():1126823. PubMed ID: 36911736
[TBL] [Abstract][Full Text] [Related]
17. Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis.
Chen S; Wang Y; Pan Y; Liu Y; Zheng S; Ding K; Mu K; Yuan Y; Li Z; Song H; Jin Y; Fu J
J Am Heart Assoc; 2020 Jun; 9(12):e015513. PubMed ID: 32476536
[TBL] [Abstract][Full Text] [Related]
18. NLRP3 inflammasome pathway in atherosclerosis: Focusing on the therapeutic potential of non-coding RNAs.
Al-Hawary SIS; Jasim SA; Romero-Parra RM; Bustani GS; Hjazi A; Alghamdi MI; Kareem AK; Alwaily ER; Zabibah RS; Gupta J; Mahmoudi R; Hosseini-Fard S
Pathol Res Pract; 2023 Jun; 246():154490. PubMed ID: 37141699
[TBL] [Abstract][Full Text] [Related]
19. NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases.
Abderrazak A; Syrovets T; Couchie D; El Hadri K; Friguet B; Simmet T; Rouis M
Redox Biol; 2015; 4():296-307. PubMed ID: 25625584
[TBL] [Abstract][Full Text] [Related]
20. NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis.
Burger F; Baptista D; Roth A; da Silva RF; Montecucco F; Mach F; Brandt KJ; Miteva K
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
